Interims
Tackling The Talent Shortfall In Cell And Gene Therapy
The Advanced Therapy Medicinal Products (ATMPs) sector, an area of medicine specialised in gene, tissue and cell therapies, is expanding at an incredibly fast...
How to navigate IR35 to secure top interim talent
In April 2021, the UK Government extended the off-payroll working (IR35) rules to the private sector; now affecting any medium and large organisations looking...
Talent in a virtual world – reflections from JP Morgan 2022
In January, I attended the 40th Annual JP Morgan Health Care Conference, the traditional kick off annual event for the global life science investment...
Interim managers can help when international travel is restricted
As the world faces an unprecedented global shutdown amid the COVID-19 pandemic, for life sciences companies it’s in the interests of everyone, not least...
Could a different approach to head office teams drive better efficiency?
When done right, an interim manager can provide a cost-effective way to access the best talent to deliver a flexible solution, whilst transferring skills...
Private sector IR35 update on the horizon yet in change lies opportunity
Interim Management is the means by which an individual provides professional services to a client-base of their choosing. It is typically delivered by highly...
Unleashing The Power of Interims
Businesses are dynamic; they grow, contract, fail and succeed. Research has firmly established that this process is vital to productivity and sustained growth in...
Brexit’s Uncertainty Principle
While the minutiae of the possible upcoming permutations for drug supply depending on various Brexit outcomes have been written about elsewhere, less thought has been...
Executive Interims: A creative talent solution for medtech
After attending two recent medtech industry meetings, I was struck by the scale of the two opposing forces that the sector is currently experiencing....
Engaging with executive interims – time for a fresh perspective
Habits are hard to break and all too often we return to established patterns of behaviour rather than looking for innovative ways to do...
The value of engaging Pharmacoeconomic executive interims
So what is Pharmacoeconomics? Pharmacoeconomics, is the “scientific discipline which evaluates the clinical, economic and humanistic aspects of pharmaceutical products, services, and programmes, as...
Interim leaders are not ‘temps’ – choose wisely and reap the rewards
We’re all familiar with the concept – there’s an absence at work and we need some cover. A quick Google search and we send...
Labelling of an Interim (or consultant; or freelancer)
I am often asked what defines an Executive Interim and the online community often seeks to debate this subject too. Veterans in the field...
Let’s face facts: it’s a candidate market for senior talent across life sciences
Tens of thousands of pharma jobs have been lost in recent years. So can smaller companies now select at leisure from an overflowing pool...
The executive interim community calls for a ‘conscious coupling’ of RPOs and interims specialists
A voice of choice is emerging from the executive interim community and this is as encouraging as it is concerning. Online forums are rife...